Adverse event | Omalizumab | Control |
Subjects n | 3678 | 2452 |
Any severe adverse event | 10.8 | 12.6 |
Headache | 1.5 | 1.6 |
Upper respiratory tract infection | 0.7 | 0.6 |
Sinusitis | 0.5 | 1.0 |
Influenza | 0.3 | 0.7 |
Nasopharyngitis | 0.2 | 0.5 |
Data are presented as %, unless otherwise stated. #: ≥0.5% in any group.